Adverum Biotechnologies
ADVM
ADVM
160 hedge funds and large institutions have $979M invested in Adverum Biotechnologies in 2020 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 67 increasing their positions, 38 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0.07% less ownership
Funds ownership: 10.07% → 10% (-0.07%)
42% less capital invested
Capital invested by funds: $1.69B → $979M (-$710M)
50% less funds holding in top 10
Funds holding in top 10: 8 → 4 (-4)
Holders
160
Holding in Top 10
4
Calls
$6.86M
Puts
$4.63M
Top Buyers
| 1 | +$22.2M | |
| 2 | +$16.6M | |
| 3 | +$16.2M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$15.4M |
| 5 |
O
OrbiMed
New York
|
+$13.3M |
Top Sellers
| 1 | -$36.5M | |
| 2 | -$11M | |
| 3 | -$10.4M | |
| 4 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$9.81M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$7.73M |